Abstract
Background: Morbidity and mortality of surgical aortic valve replacement (AVR) are increased in patients with previous heart surgery. Especially patients after homograft AVR carry an increased risk. Transapical aortic valve implantation (TAVI) may be an option to reduce mortality and morbidity in this special patient group.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
